Measuring Health-Related Quality of Life in Pediatric Neurology

Monica E Lemmon1,2,3, Hanna E Huffstetler2, Bryce B Reeve1,3,4

  • 1Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Insights

Understanding health-related quality of life (HRQOL) is crucial for pediatric neurology care. This review clarifies HRQOL measurement challenges and principles for children with neurodevelopmental impairments.

Area of Science:

  • Pediatric Neurology
  • Health Outcomes Research
  • Neurodevelopmental Disorders

Background:

  • Health-related quality of life (HRQOL) significantly influences clinical decision-making and parental planning for children with neurologic conditions.
  • Accurate assessment of HRQOL is essential for informed care but faces unique challenges in pediatric neurology.
  • Understanding HRQOL definitions and measurement is vital for effective management of pediatric neurodevelopmental impairment.

Purpose of the Study:

  • To review the challenges in measuring HRQOL within pediatric neurology.
  • To examine current HRQOL measurement tools applicable to children with neurologic conditions.
  • To provide guidance on selecting and interpreting HRQOL measures for this population.

Main Methods:

  • Literature review of HRQOL measurement in pediatric neurology.
  • Analysis of existing HRQOL assessment instruments.
  • Synthesis of key principles for HRQOL measure application.

Main Results:

  • Identified significant challenges in defining and measuring HRQOL in pediatric neurodevelopmental impairment.
  • Evaluated the suitability of various existing HRQOL measures for children with neurologic conditions.
  • Outlined critical principles for the appropriate selection and interpretation of HRQOL data.

Conclusions:

  • Effective HRQOL measurement is key to supporting informed decision-making for children with neurologic conditions.
  • Guidance on HRQOL measure selection and interpretation is necessary for clinicians and parents.
  • Further research may be needed to refine HRQOL assessment in pediatric neurology.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
123
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147